The N-terminal Region of NTAK/Neuregulin-2 Isoforms Has an Inhibitory Activity on Angiogenesis

This publication has 23 references indexed in Scilit:

• Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
  Oncogene, 1999
• Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
  Nature, 1997
• Ligands for ErbB-family receptors encoded by a neuregulin-like gene
  Nature, 1997
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996
• ARIA can be released from extracellular matrix through cleavage of a heparin-binding domain.
  The Journal of cell biology, 1995
• The retinoblastoma protein and cell cycle control
  Cell, 1995
• Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
  Cell, 1994
• Inhibitory effects of anti-angiogenic agents on neovascularization and growth of the chorioallantoic membrane (CAM). — The possibility of a new CAM assay for angiogenesis inhibition
  Experimental pathology, 1986
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
  Nature, 1984